Quintiles sets up in Ghana to boost recruitment pool

By Gareth Macdonald

- Last updated on GMT

UK CRO Quintiles Transnational has set up an office in Accra, Ghana in a move it claims allows it to recruit trial participants from sub-Saharan Africa’s estimated 760m residents.

The pharmaceutical industry’s growing demand for treatment naive populations has seen contract research organisations (CRO) enter various new markets in recent years, with Asia, South America and Central and Eastern Europe being the key beneficiaries.

This month alone US CRO Kendle has set up offices in Malaysia, Thailand and the Philippines while compatriot PRA bolstered its presence in Brazil.

In addition, the Russian trials sector has attracted a lot of attention most recently on June 2 when a Synergy Research Group report described it as a “potential superpower” in the market in years to come.

Africa too has benefited from the CRO sector’s expansion with, for example, patient recruitment specialist Synexus announcing plans to double its South African trial capacity in December.

In February, the European Union provided €3m ($4.15m) funding for a network to promote excellence in clinical trials through its​European & Developing Countries Clinical Trials Partnership (EDCTP) unit.

Important for patient recruitment

Quintiles did not respond to Outsourcing-pharma’s request for further information, however, in a press release issued by the firm​Gillian Corken, its CEO in Africa, set out the sorts of studies the new office will oversee.

Corken said that: “Initially the focus will be on diseases such as malaria, TB and HIV,”​ such as the trial of a malaria vaccine that the firm recently began.

However, we anticipate that as the infrastructure and economies in Africa develop… it will play an increasingly important role in recruiting patients for many other therapeutic areas, such as oncology and cardiovascular.

Quintiles’ Accra office is based in the grounds of the University of Ghana at the Noguchi Memorial Institute for Medical Research.

In addition to managing its local trial activities, Quintiles office will provide training for new investigators across a range of therapeutic areas, as well as an education programme for clinical research associates (CRAs).

Ethical practices

Quintiles also stressed that, as with its other units worldwide, its Ghanian office will “strictly adhere to ethical principles articulated by international guidelines such as ICH, the Declaration of Helsinki, CIOMS and the Belmont Report​.”

The firm’s emphasis on the ethics is perhaps unsurprising given some recent criticism of practices employed during trials in Africa, most notably Pfizer’s Nigerian Trovan study, and throughout the developing world as a whole.

Related news

Show more

Related products

show more

Using Define-XML to build more efficient studies

Using Define-XML to build more efficient studies

Content provided by Formedix | 14-Nov-2023 | White Paper

It is commonly thought that Define-XML is simply a dataset descriptor: a way to document what datasets look like, including the names and labels of datasets...

Overcoming rapid growth challenges with process liquid preparation

Overcoming rapid growth challenges with process liquid preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 01-Nov-2023 | Case Study

A growing contract development manufacturing organization (CDMO) was challenged with the need to quickly expand their process liquid and buffer preparation...

Why should you use clinical trial technology?

Why should you use clinical trial technology?

Content provided by Formedix | 01-Nov-2023 | White Paper

New, innovative clinical trial technology is helping to revolutionize the research landscape. COVID-19 demonstrated that clinical trials can be run much...

Related suppliers

Follow us

Products

View more

Webinars